Re: A Randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15292391

J. Natl. Cancer Inst. 2004 Aug 4 96 15 1183; author reply 1183-1184

Download in:

View as

General Info

PMID
15292391